Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-198,400
Closed -$8.99M 10564
2025
Q3
$8.99M Buy
+198,400
New +$8.03M ﹤0.01% 3415
2019
Q4
Sell
-9,000
Closed -$442K 8125
2019
Q3
$442K Buy
+9,000
New +$406K ﹤0.01% 4665
2015
Q1
Sell
-10,000
Closed -$207K 8865
2014
Q4
$207K Buy
+10,000
New +$199K ﹤0.01% 5005

Other funds holding CGNX

UBS Group's CGNX Position: Q1 2026 in Review

UBS Group reduced its Cognex (CGNX) stake by 36% in Q1 2026, selling an estimated $13.8M and leaving 526,396 shares worth $25.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

UBS Group first reported a position in CGNX in Q4 2014 and has held it in 46 quarters since. The position peaked at $54.5M in Q3 2025. 570 funds tracked by Wall St. Rank hold CGNX as of Q1 2026.

  • UBS Group held 526,396 shares of Cognex worth $25.8M as of Q1 2026.
  • UBS Group sold 294,754 Cognex shares in Q1 2026, an estimated $13.8M.
  • Cognex made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2317 holding.
  • UBS Group first reported a position in Cognex in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Cognex position peaked at $54.5M in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Cognex as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.